Peer-reviewed veterinary case report
Successful treatment of a South African cat with effusive feline infectious peritonitis with remdesivir.
- Journal:
- Journal of the South African Veterinary Association
- Year:
- 2022
- Authors:
- Bohm, M
- Affiliation:
- King Edward Veterinary Referral Hospital
- Species:
- cat
Plain-English summary
A young cat in South Africa was diagnosed with a serious condition called effusive feline infectious peritonitis (FIP), which has often been fatal in the past. Thanks to recent research inspired by the COVID-19 pandemic, a treatment called remdesivir has been found to be effective for FIP. The cat received this medication daily for 80 days, and it showed a complete recovery. This case highlights the potential of remdesivir as a successful treatment for FIP in cats.
Abstract
Historically, feline infectious peritonitis (FIP) has been considered almost invariably fatal. The recent COVID-19 pandemic has fuelled research in coronavirus pathophysiology and treatment. An unintended consequence is that we now have an effective treatment accessible for FIP. This paper reports on the successful resolution of immunohistochemistry-confirmed effusive FIP in an adolescent cat in South Africa following monotherapy with remdesivir at 4.9-5.6 mg/kg daily for 80 days.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/35934910/